↓ Skip to main content

Alpha 2 Delta (α2δ) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome

Overview of attention for article published in Frontiers in Pharmacology, January 2011
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
49 Dimensions

Readers on

mendeley
84 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Alpha 2 Delta (α2δ) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome
Published in
Frontiers in Pharmacology, January 2011
DOI 10.3389/fphar.2011.00028
Pubmed ID
Authors

Jeremy D. Gale, Lesley A. Houghton

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Unknown 82 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 14%
Student > Master 12 14%
Other 11 13%
Researcher 10 12%
Student > Postgraduate 9 11%
Other 17 20%
Unknown 13 15%
Readers by discipline Count As %
Medicine and Dentistry 24 29%
Agricultural and Biological Sciences 11 13%
Nursing and Health Professions 6 7%
Pharmacology, Toxicology and Pharmaceutical Science 5 6%
Psychology 5 6%
Other 20 24%
Unknown 13 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 June 2011.
All research outputs
#15,675,797
of 23,294,050 outputs
Outputs from Frontiers in Pharmacology
#6,712
of 16,728 outputs
Outputs of similar age
#142,574
of 182,815 outputs
Outputs of similar age from Frontiers in Pharmacology
#27
of 44 outputs
Altmetric has tracked 23,294,050 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,728 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 182,815 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.